Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia

Title
Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia
Authors
Keywords
-
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume 10, Issue 5, Pages 361-368
Publisher
Elsevier BV
Online
2010-11-11
DOI
10.3816/clml.2010.n.069

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started